Challenges of CRISPR-Based Gene Editing in Primary T Cells.

Rezalotfi, Alaleh; Fritz, Lea; Förster, Reinhold; Bosnjak, Berislav

Rezalotfi, Alaleh; Fritz, Lea; Förster, Reinhold; Bosnjak, Berislav.

Afiliação

Rezalotfi A; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.
Fritz L; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.
Förster R; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.
Bosnjak B; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625 Hannover, Germany.

Int J Mol Sci ; 23(3)2022 Feb 01.

Article em En | MEDLINE | ID: mdl-35163611

Assuntos

Sistemas CRISPR-Cas; Edição de Genes/métodos; Imunoterapia; Linfócitos T; Humanos

Palavras-chave

CAR T cells; CRISPR/Cas9; T cells; adoptive T-cell therapy; gene modifications

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Sistemas CRISPR-Cas / Edição de Genes / Imunoterapia Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google